Pharmacovigilance: an activity aimed to identify, evaluate, understand and prevent the undesirable consequences of medical drugs application.
Pharmacovigilance activities procedure is established by the Technical Code of Common Practice TCCP 564-2015 (33050) “GOOD PHARMACOVIGILANCE PRACTICIES (GVP)”, which was introduced in the Republic of Belarus for the first time and entered into force on 15-08-2015.
In order to carry out activities reffered to drug safety evaluation with early recognition of all changes in a benefit/risk ratio of the drugs produced by Foreign Unitary Enterprise "REB-PHARMA", and to develope and implement measures ensuring the use of "REB-PHARMA" medicines when benefits exceed risks, the pharmacovigilance department was founded at our enterprise.
Top-priority tasks of Pharmacovigilance Service established at Foreign Unitary Enterprise "REB-PHARM are to prevent the undesirable consequences while using the registered drugs produced by our company and to protect patients and public health. That is why the collection of information related to the safety and effectiveness of REB-PHARMA medicines is an important part of our work. Pharmacovigilance
Pharmacovigilance authorized person at the enterprise:
Moshkina Elena Ivanovna - Pharmacovigilance authorized person, The Head of Pharmacovigilance department.
Postal address: Foreign Unitary Enterprise "REB-PHARMA",
Kollectornaya str., 3A, office 320, 220004, Minsk, Republic of Belarus.
Phone: +375 17 2402634 , fax: +375 17 2402635 .
24-hour Mobile phone for 24-hour access: +375 44 7304390 .
Email Address: pharmacovigilance@rebpharma.by
If you have any information about an undesired (suspected) reaction or lack of effectiveness when using medicines manufactured by Foreign Unitary Enterprise "Reb-Pharma", please inform us about it by the phone and email mentioned above and / or fill out the form using the links below. Before filling out the form, please study the terms and definitions from TCCP 564-2015 (33050).
As to the receipt of your message, the person responsible for pharmacovigilance will certainly contact you.
We guarantee confidentiality of personal data and documentation provided by you, except for the cases established by the requirements of applicable national legislation.